Quick Takeaways
- Anthony Hunt has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $11,609,711.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Anthony Hunt
- Location
- Waltham, MA
- Summary
- The estimated net worth of Anthony Hunt is at least $11,609,711 dollars as of 03 Mar 2026. Anthony Hunt is the Director of REPLIGEN CORP and owns shares of REPLIGEN CORP (RGEN) stock worth about $11.13M. Anthony Hunt is the Director of BIOLIFE SOLUTIONS INC and owns shares of BIOLIFE SOLUTIONS INC (BLFS) stock worth about $339.7K. Anthony Hunt is the Director of 908 Devices Inc. and owns shares of 908 Devices Inc. (MASS) stock worth about $139.9K.
- Signature
- /s/ Jennifer Carmichael (Attorney in Fact)
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anthony Hunt and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: REPLIGEN CORP ($11,130,078).
- Past-year value change for that position: -$13,794,295.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Anthony Hunt
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Director | $11,130,078 | -$13,794,295 | -55% | 02 Mar 2026 |
| BLFS | BIOLIFE SOLUTIONS INC | Director | $339,738 | 24 Feb 2026 | ||
| MASS | 908 Devices Inc. | Director | $139,895 | 11 Jun 2025 |
Insider Transactions Reported by Anthony Hunt:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.